Journey Medical (DERM)
(Delayed Data from NSDQ)
$4.83 USD
+0.32 (7.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.87 +0.04 (0.83%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for Journey Medical Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 27 | 32 | 49 | 8 | 5 |
Receivables | 15 | 28 | 23 | 24 | 19 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 10 | 14 | 10 | 1 | 1 |
Other Current Assets | 4 | 3 | 2 | 2 | 1 |
Total Current Assets | 56 | 78 | 84 | 35 | 25 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 1 | 1 |
Intangibles | 20 | 27 | 13 | 15 | 7 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 77 | 105 | 97 | 52 | 34 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 18 | 37 | 23 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 3 | 1 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 20 | 20 | 23 | 22 | 19 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 7 | 5 | 5 | 0 |
Total Current Liabilities | 42 | 67 | 52 | 28 | 21 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 15 | 20 | 0 | 5 | 5 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 4 | 8 | 5 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 57 | 88 | 55 | 42 | 31 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 93 | 85 | 81 | 5 | 3 |
Retained Earnings | -72 | -69 | -39 | 5 | 0 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 20 | 17 | 42 | 10 | 3 |
Total Liabilities & Shareholder's Equity | 77 | 105 | 97 | 52 | 34 |
Total Common Equity | 20 | 17 | 42 | 10 | 3 |
Shares Outstanding | 19.30 | 17.70 | 17.30 | NA | NA |
Book Value Per Share | 1.05 | 0.96 | 2.43 | 0.00 | 0.00 |
Fiscal Year End for Journey Medical Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 24 | 24 | 27 | 25 | 17 |
Receivables | 10 | 10 | 15 | 8 | 17 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 10 | 11 | 10 | 11 | 12 |
Other Current Assets | 2 | 3 | 4 | 1 | 2 |
Total Current Assets | 46 | 47 | 56 | 45 | 48 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 19 | 19 | 20 | 21 | 22 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 65 | 67 | 77 | 66 | 70 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 15 | 16 | 18 | 29 | 32 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 10 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 16 | 20 | 20 | 16 | 23 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 3 | 3 | 3 | 2 |
Total Current Liabilities | 34 | 39 | 42 | 49 | 68 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 20 | 15 | 15 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 54 | 54 | 57 | 49 | 70 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 97 | 96 | 93 | 88 | 87 |
Retained Earnings | -86 | -83 | -72 | -70 | -87 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 11 | 13 | 20 | 17 | 0 |
Total Liabilities & Shareholder's Equity | 65 | 67 | 77 | 66 | 70 |
Total Common Equity | 11 | 13 | 20 | 17 | 0 |
Shares Outstanding | 20.00 | 19.90 | 19.30 | 18.50 | 18.10 |
Book Value Per Share | 0.57 | 0.65 | 1.05 | 0.94 | 0.00 |